Neuphoria Therapeutics Inc.

NEUP ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $27.6M

Liabilities Breakdown FY2024

Total Liabilities: $10.2M